A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects

被引：0
|
作者：
Hironobu Tsukada
Yu-Luan Chen
Guangqing Xiao
Lisa Lennek
Snezana M. Milanovic
MaryAlice Worden
Daniel G. Polhamus
Yu-Yuan Chiu
Seth C. Hopkins
Gerald R. Galluppi
机构：
[1] Sumitomo Pharma America,
[2] Sumitomo Pharma Co.,undefined
[3] Ltd,undefined
[4] Metrum Research Group,undefined
来源：
Clinical Pharmacokinetics | 2023年 / 62卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1755 / 1763
页数：8
相关论文
共 50 条
  • [11] Inhibition of cytochrome P450 2D6 by a series of quinidine and quinine analogs
    Hutzler, JM
    Walker, GS
    Wienkers, LC
    FASEB JOURNAL, 2003, 17 (04): : A611 - A611
  • [12] Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)
    Desta, Z
    Kerbusch, T
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 10 - 20
  • [13] Inhibition of cytochrome P450 2D6 modifies codeine abuse liability
    Kathiramalainathan, K
    Kaplan, HL
    Romach, MK
    Busto, UE
    Li, NY
    Säwe, J
    Tyndale, RF
    Sellers, EM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (04) : 435 - 444
  • [14] INHIBITION OF HUMAN CYTOCHROME P450 2D6 (CYP2D6) BY METHADONE
    WU, D
    OTTON, SV
    SPROULE, BA
    BUSTO, U
    INABA, T
    KALOW, W
    SELLERS, EM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (01) : 30 - 34
  • [15] Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study
    Cao, Guoying
    Yang, Haijing
    Wang, Jingjing
    Ishida, Masahiro
    Thoma, Christian
    Haeufel, Thomas
    Bossert, Sebastian
    Zhang, Jing
    ADVANCES IN THERAPY, 2024, 41 (09) : 3557 - 3568
  • [16] Analysis of phase of duplication in cytochrome P450 2D6 duplication samples
    Kramer, Whitney E.
    Fisher, Pamela K.
    Walker, Denise A.
    O'Kane, Dennis J.
    Mrazek, David A.
    Black, John Logan
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 123S - 124S
  • [17] Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers
    Madani, S
    Barilla, D
    Cramer, J
    Wang, YB
    Paul, C
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1211 - 1218
  • [18] Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians
    Gogtay, Nithya J.
    Mali, Nitin B.
    Iyer, Krishna
    Kadam, Prashant P.
    Sridharan, Kannan
    Shrimal, Divya
    Thatte, Urmila M.
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (03) : 266 - 269
  • [19] Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation
    Niwa, Toshiro
    Sasaki, Shoko
    Yamamoto, Yuka
    Tanaka, Mayu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2022, 47 (05) : 741 - 747
  • [20] EFFECT OF CYTOCHROME P450 2D6 ON RISPERIDONE PHARMACOKINETICS AND EXTRAPYRAMIDAL SYMPTOMS IN HEALTHY VOLUNTEERS: RESULTS FROM A PHARMACOGENETIC CLINICAL TRIAL
    Lafuente, A.
    Arnaiz, J. A.
    Gasso, P.
    Mas, S.
    Bioque, M.
    Carne, X.
    Bernardo, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 22 - 22
12345